Autophagy in polyglutamine disease: Imposing order on disorder or contributing to the chaos?

Molecular and Cellular Neuroscience

Volumn 66, Issue PA, 2015, Pages 53-61

  Cortes, Constanza J ^a   La Spada, Albert R ^a,b,c,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLUTAMINE;

AUTOPHAGOSOME; AUTOPHAGY; CAG REPEAT; CYTOSOL; DEGENERATIVE DISEASE; DENTATORUBROPALLIDOLUYSIAN ATROPHY; GENE EXPRESSION; GENETIC CODE; HISTONE ACETYLATION; HUMAN; HUNTINGTON CHOREA; KENNEDY DISEASE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN LOCALIZATION; REVIEW; SPINOCEREBELLAR DEGENERATION; UBIQUITINATION;

EID: 84929702384     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2015.03.010     Document Type: Review

References (86)

1. Alves S., et al. The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice. Acta Neuropathol. 2014, 128(5):705-722.
2. Atwal R.S., et al. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum. Mol. Genet. 2007, 16(21):2600-2615.
3. Berger Z., et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 2006, 15(3):433-442.
4. Bilen J., Bonini N.M. Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet. 2007, 3(10):1950-1964.
5. Burnett B., Li F., Pittman R.N. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum. Mol. Genet. 2003, 12(23):3195-3205.
6. Cary G.A., La Spada A.R. Androgen receptor function in motor neuron survival and degeneration. Phys. Med. Rehabil. Clin. N. Am. 2008, 19(3):479-494. (viii).
7. Choi A.M., Ryter S.W., Levine B. Autophagy in human health and disease. N. Engl. J. Med. 2013, 368(7):651-662.
8. Chua J.P., et al. Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy. Hum. Mol. Genet. 2014, 23(5):1376-1386.
9. Cortes C.J., et al. Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat. Neurosci. 2014, 17(9):1180-1189.
10. Cortes C.J., et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 2014, 82(2):295-307.
11. Cui L., et al. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 2006, 127(1):59-69.
12. Dejager S., et al. A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J. Clin. Endocrinol. Metab. 2002, 87(8):3893-3901.
13. Doi H., et al. p62/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse model. J. Neurosci. 2013, 33(18):7710-7727.
14. Du X., et al. Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6. Cell 2013, 154(1):118-133.
15. Duarte-Silva S., et al. Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease. Cerebellum 2014, 13(6):713-727.
16. Dubinsky A.N., et al. Let-7 coordinately suppresses components of the amino acid sensing pathway to repress mTORC1 and induce autophagy. Cell Metab. 2014, 20(4):626-638.
17. Dyer R.B., McMurray C.T. Mutant protein in Huntington disease is resistant to proteolysis in affected brain. Nat. Genet. 2001, 29(3):270-278.
18. Fox J.H., et al. The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease. Mol. Neurodegener. 2010, 5:26.
19. Hara T., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441(7095):885-889.
20. Ishikawa K., et al. Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum. Mol. Genet. 1999, 8(7):1185-1193.
21. Iwata A., et al. Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(37):13135-13140.
22. Jia D.D., et al. Lithium chloride alleviates neurodegeneration partly by inhibiting activity of GSK3beta in a SCA3 Drosophila model. Cerebellum 2013, 12(6):892-901.
23. Katsuno M., et al. Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. J. Neurosci. 2010, 30(16):5702-5712.
24. Katsuno M., et al. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Prog. Neurobiol. 2012, 99(3):246-256.
25. Kegel K.B., et al. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J. Neurosci. 2000, 20(19):7268-7278.
26. Komatsu M., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441(7095):880-884.
27. La Spada A.R., Taylor J.P. Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat. Rev. Genet. 2010, 11(4):247-258.
28. La Spada A.R., et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991, 352(6330):77-79.
29. Lam Y.C., et al. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 2006, 127(7):1335-1347.
30. Lee H., et al. IRE1 plays an essential role in ERstress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux. Hum. Mol. Genet. 2012, 21(1):101-114.
31. Lee J.H., et al. Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes. Neuron 2015, 85(2):303-315.
32. Lee L.C., et al. Role of high mobility group box 1 (HMGB1) in SCA17 pathogenesis. PLoS One 2014, 9(12):e115809.
33. Liang C.C., et al. Neural-specific deletion of FIP200 leads to cerebellar degeneration caused by increased neuronal death and axon degeneration. J. Biol. Chem. 2010, 285(5):3499-3509.
34. Lieberman A.P., et al. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep. 2014, 7(3):774-784.
35. Lu K., Psakhye I., Jentsch S. Autophagic clearance of polyQ proteins mediated by ubiquitin-Atg8 adaptors of the conserved CUET protein family. Cell 2014, 158(3):549-563.
36. Martinez-Vicente M., et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci. 2010, 13(5):567-576.
37. McCampbell A., et al. CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 2000, 9(14):2197-2202.
38. Mealer R.G., et al. Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy. J. Biol. Chem. 2014, 289(6):3547-3554.
39. Menzies F.M., et al. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain 2010, 133(Pt 1):93-104.
40. Metzger S., et al. Age at onset in Huntington's disease is modified by the autophagy pathway: implication of the V471A polymorphism in Atg7. Hum. Genet. 2010, 128(4):453-459.
41. Montie H.L., et al. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2009, 18(11):1937-1950.
42. Mookerjee S., et al. Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminalcaspase-7 cleavage fragment. J. Neurosci. 2009, 29(48):15134-15144.
43. Nascimento-Ferreira I., et al. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease. Brain 2011, 134(Pt 5):1400-1415.
44. Nascimento-Ferreira I., et al. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease. Brain 2013, 136(Pt 7):2173-2188.
45. Nedelsky N.B., et al. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron 2010, 67(6):936-952.
46. Nisoli I., et al. Neurodegeneration by polyglutamine Atrophin is not rescued by induction of autophagy. Cell Death Differ. 2010, 17(10):1577-1587.
47. Ochaba J., et al. Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(47):16889-16894.
48. Pandey U.B., et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007, 447(7146):859-863.
49. Park S.H., et al. PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell 2013, 154(1):134-145.
50. Pryor W.M., et al. Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease. Sci. Signal. 2014, 7(349):ra103.
51. Qi M.L., et al. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases. Nat. Cell Biol. 2007, 9(4):402-414.
52. Qin Z.H., et al. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum. Mol. Genet. 2003, 12(24):3231-3244.
53. Qin Z.H., et al. Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction. J. Neurosci. 2004, 24(1):269-281.
54. Ravikumar B., Duden R., Rubinsztein D.C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 2002, 11(9):1107-1117.
55. Ravikumar B., et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 2004, 36(6):585-595.
56. Rusmini P., et al. Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy. Neurobiol. Dis. 2010, 40(2):361-369.
57. Rusmini P., et al. 17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy. Neurobiol. Dis. 2011, 41(1):83-95.
58. Sandri M., et al. Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies. J. Cell Sci. 2013, 126(Pt 23):5325-5333.
59. Sapp E., et al. Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 1997, 42(4):604-612.
60. Seredenina T., Gokce O., Luthi-Carter R. Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation. PLoS One 2011, 6(7):e22231.
61. Settembre C., et al. A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet. 2008, 17(1):119-129.
62. Settembre C., et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat. Cell Biol. 2013, 15(6):647-658.
63. Shibata M., et al. Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J. Biol. Chem. 2006, 281(20):14474-14485.
64. Silva-Fernandes A., et al. Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease. Neurotherapeutics 2014, 11(2):433-449.
65. Sopher B.L., et al. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron 2004, 41(5):687-699.
66. Subramaniam S., et al. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 2009, 324(5932):1327-1330.
67. Subramaniam S., et al. Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. Nat. Neurosci. 2012, 15(2):191-193.
68. Tang D., et al. Endogenous HMGB1 regulates autophagy. J. Cell Biol. 2010, 190(5):881-892.
69. Taylor J.P., et al. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 2003, 12(7):749-757.
70. Tellez-Nagel I., Johnson A.B., Terry R.D. Studies on brain biopsies of patients with Huntington's chorea. J. Neuropathol. Exp. Neurol. 1974, 33(2):308-332.
71. Terman A., et al. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid. Redox Signal. 2010, 12(4):503-535.
72. Thompson L.M., et al. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J. Cell Biol. 2009, 187(7):1083-1099.
73. Tohnai G., et al. Paeoniflorin eliminates a mutant AR via NF-YA-dependent proteolysis in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2014, 23(13):3552-3565.
74. Tokui K., et al. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Hum. Mol. Genet. 2009, 18(5):898-910.
75. Tsunemi T., et al. PGC-1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci. Transl. Med. 2012, 4(142):142ra97.
76. Unno T., et al. Development of Purkinje cell degeneration in a knockin mouse model reveals lysosomal involvement in the pathogenesis of SCA6. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(43):17693-17698.
77. Vig P.J., et al. Bergmann glial S100B activates myo-inositol monophosphatase 1 and co-localizes to purkinje cell vacuoles in SCA1 transgenic mice. Cerebellum 2009, 8(3):231-244.
78. Waza M., et al. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med. 2005, 11(10):1088-1095.
79. Weydt P., et al. The gene coding for PGC-1alpha modifies age at onset in Huntington's disease. Mol. Neurodegener. 2009, 4:3.
80. Wong E., Cuervo A.M. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 2010, 13(7):805-811.
81. Yang X.W., Yamamoto A. CLEARance wars: polyQ strikes back. Nat. Neurosci. 2014, 17(9):1140-1142.
82. Yu Z., et al. Macroautophagy is regulated by the UPR-mediatorCHOP and accentuates the phenotype of SBMA mice. PLoS Genet. 2011, 7(10):e1002321.
83. Yu X., et al. Differential degradation of full-length and cleaved ataxin-7 fragments in a novel stable inducible SCA7 model. J. Mol. Neurosci. 2012, 47(2):219-233.
84. Yu X., et al. Inhibition of autophagy via p53-mediated disruption of ULK1 in a SCA7 polyglutamine disease model. J. Mol. Neurosci. 2013, 50(3):586-599.
85. Zander C., et al. Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3. Hum. Mol. Genet. 2001, 10(22):2569-2579.
86. Zheng S., et al. Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet. 2010, 6(2):e1000838.